Mazzoni Center examines PrEP safety alongside HRT

A local LGBTQ+ health and wellness center is expanding its work into clinical research. Mazzoni Center launched a clinical research department in October, guided by a goal of expanding access to emerging healthcare initiatives and ensuring LGBTQ+ people are more strongly represented in academic research. The organization plans to launch more clinical trials in spring 2027 and is now a few weeks into its first study with hopes of demonstrating the safety and efficacy of oral PrEP for people using gender-affirming hormone therapies. “We could not have a more well-suited study for us — or vice versa,” said Wil Vickroy, the organization’s director of clinical research — who was proud to note that Mazzoni Center was the first institution to activate globally for this trial, enrolling the first patient two days ahead of schedule.

This excerpt comes from the named source. Read the original for the full reporting.